Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 718 (USA) (Dr. Nolan)
· consented 2013-02-01
Adverse events
4
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
mild
assessed
2026-08-18
Mild APPLICATION SITE DERMATITIS — outcome: RECOVERED/RESOLVED; onset 2013-03-23 (study day 51.0); relationship: PROBABLE
mild
assessed
2026-08-18
Mild APPLICATION SITE IRRITATION — outcome: RECOVERED/RESOLVED; onset 2013-03-23 (study day 51.0); relationship: PROBABLE
mild
assessed
2026-08-18
Mild APPLICATION SITE IRRITATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-04-02 (study day 61.0); relationship: PROBABLE
moderate
assessed
2026-08-18
Moderate APPLICATION SITE IRRITATION — outcome: RECOVERED/RESOLVED; onset 2013-04-02 (study day 61.0); relationship: PROBABLE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.